Clinical Trials Logo

Pyloric Stenosis;Acquired clinical trials

View clinical trials related to Pyloric Stenosis;Acquired.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT04496050 Active, not recruiting - Clinical trials for Congenital Heart Disease

Effects of Prostaglandin E1 Treatment on Pyloric Wall in Newborns

EOPTOPWT
Start date: May 6, 2019
Phase:
Study type: Observational [Patient Registry]

Prostaglandin E1 (PGE1) has been used in the medical treatment of ductal dependent critical congenital heart disease in neonates. Apnea/ bradycardia, hypotension, hypokalemia, feeding difficulties, fever, jitteriness are the most important side effects of PGE1. Also gastric outlet has been reported. We aimed to determine effect of PGE1 treatment on pyloric wall thickness in newborn period. In this study, the side effect of increase of pylorus muscle wall thickness will be monitored with weekly ultrasonography. No intervention in the treatment, medical decisions and follow-up of these patients will be made. After reaching the sufficient number of cases (20 cases), increases in the pyloric wall thickness dimensions will be compared with statistical analysis. The number of cases was determined in accordance with the rate of hospitalization in our unit during the determined period (18 months).